Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Growth Control of Adherent-Invasive Escherichia coli (AIEC) by the Predator Bacteria Bdellovibrio bacteriovorus: A New Therapeutic Approach for Crohn's Disease Patients.

Bonfiglio G, Neroni B, Radocchia G, Pompilio A, Mura F, Trancassini M, Di Bonaventura G, Pantanella F, Schippa S.

Microorganisms. 2019 Dec 20;8(1). pii: E17. doi: 10.3390/microorganisms8010017.

2.

Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients.

Bruno G, Gagliardi A, Oliva A, Trancassini M, Macone A, Cicerone C, D'Abramo A, Iebba V, Auria S, Bonfiglio G, Zingaropoli MA, D'Ettorre G, Badiali D, Vullo V, Corazziari ES, Schippa S.

New Microbiol. 2019 Oct;42(4):221-224. Epub 2019 Oct 14.

3.

Rebuilding the Gut Microbiota Ecosystem.

Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, Trancassini M, Passariello C, Pantanella F, Schippa S.

Int J Environ Res Public Health. 2018 Aug 7;15(8). pii: E1679. doi: 10.3390/ijerph15081679. Review.

4.

Behaviour of Bdellovibrio bacteriovorus in the presence of Gram-positive Staphylococcus aureus.

Pantanella F, Iebba V, Mura F, Dini L, Totino V, Neroni B, Bonfiglio G, Maria T, Passariello C, Schippa S.

New Microbiol. 2018 Apr;41(2):145-152. Epub 2018 Mar 2.

5.

Improving post-stroke cognitive and behavioral abnormalities by using virtual reality: A case report on a novel use of nirvana.

De Luca R, Torrisi M, Piccolo A, Bonfiglio G, Tomasello P, Naro A, Calabrò RS.

Appl Neuropsychol Adult. 2018 Nov-Dec;25(6):581-585. doi: 10.1080/23279095.2017.1338571. Epub 2017 Oct 11.

PMID:
29020466
6.

Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment.

Mason C, Mason J, Culme-Seymour EJ, Bonfiglio GA, Reeve BC.

Cell Stem Cell. 2013 Jun 6;12(6):644-7. doi: 10.1016/j.stem.2013.05.017.

7.

The global cell therapy industry continues to rise during the second and third quarters of 2012.

Mason C, McCall MJ, Culme-Seymour EJ, Suthasan S, Edwards-Parton S, Bonfiglio GA, Reeve BC.

Cell Stem Cell. 2012 Dec 7;11(6):735-9. doi: 10.1016/j.stem.2012.11.013.

8.

Promising growth and investment in the cell therapy industry during the first quarter of 2012.

Brindley DA, Davie NL, Sahlman WA, Bonfiglio GA, Culme-Seymour EJ, Reeve BC, Mason C.

Cell Stem Cell. 2012 May 4;10(5):492-6. doi: 10.1016/j.stem.2012.04.018.

9.

The impact of market volatility on the cell therapy industry.

Brindley DA, Reeve BC, Sahlman WA, Bonfiglio GA, Davie NL, Culme-Seymour EJ, Mason C.

Cell Stem Cell. 2011 Nov 4;9(5):397-401. doi: 10.1016/j.stem.2011.10.010. Review.

10.

Occurrence of extended spectrum beta-lactamases among isolates of Enterobacteriaceae from urinary tract infections in southern Italy.

Caccamo M, Perilli M, Celenza G, Bonfiglio G, Tempera G, Amicosante G.

Microb Drug Resist. 2006 Winter;12(4):257-64.

PMID:
17227211
11.

Topical kanamycin: an effective therapeutic option in aerobic vaginitis.

Tempera G, Abbadessa G, Bonfiglio G, Cammarata E, Cianci A, Corsello S, Raimondi A, Ettore G, Nicolosi D, Furneri PM.

J Chemother. 2006 Aug;18(4):409-14.

PMID:
17024797
12.

Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study.

Bonfiglio G, Mattina R, Lanzafame A, Cammarata E, Tempera G; Italian Medici Medicina Generale (MMG) Group.

Chemotherapy. 2005 May;51(2-3):162-6. Epub 2005 May 9.

PMID:
15886477
13.

In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.

Lanzafame A, Bonfiglio G, Santini L, Mattina R.

Chemotherapy. 2005 Mar;51(1):44-50. Epub 2005 Mar 14.

PMID:
15767745
14.

In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophila.

Bonfiglio G, Lanzafame A, Santini L, Mattina R.

J Chemother. 2004 Oct;16(5):502-3. No abstract available.

PMID:
15565921
15.

Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study.

Tempera G, Bonfiglio G, Cammarata E, Corsello S, Cianci A.

Int J Antimicrob Agents. 2004 Jul;24(1):85-8.

PMID:
15225868
16.

Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.

Tempera G, Mirabile M, Mangiafico A, Caccamo M, Bonfiglio G.

J Chemother. 2004 Apr;16(2):216-7. No abstract available.

PMID:
15216960
17.

Effects of leflunomide on human cartilage.

Panico A, Cardile V, Gentile B, Garufi F, Fama' P, Bonfiglio G, Ronsisvalle G.

Farmaco. 2003 Sep;58(9):983-7.

PMID:
13679195
18.

Effects on adhesiveness and hydrophobicity of sub-inhibitory concentrations of netilmicin.

Furneri PM, Garozzo A, Musumarra MP, Scuderi AC, Russo A, Bonfiglio G.

Int J Antimicrob Agents. 2003 Aug;22(2):164-7.

PMID:
12927958
19.

Antibiotic resistance in Burkina Faso.

Bonfiglio G, Simporè J, Pignatelli S, Musumeci S.

New Microbiol. 2003 Jul;26(3):263-8.

PMID:
12901422
20.

Risk associated with pregnancy in hypertrophic cardiomyopathy.

Autore C, Conte MR, Piccininno M, Bernabò P, Bonfiglio G, Bruzzi P, Spirito P.

J Am Coll Cardiol. 2002 Nov 20;40(10):1864-9.

21.

Epidemiology of bacterial resistance in gastro-intestinal pathogens in a tropical area.

Bonfiglio G, Simporè J, Pignatelli S, Musumeci S, Solinas ML.

Int J Antimicrob Agents. 2002 Nov;20(5):387-9.

PMID:
12431876
22.

Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae: an Italian survey.

Bonfiglio G, Perilli M, Stefani S, Amicosante G, Nicoletti G.

Int J Antimicrob Agents. 2002 Mar;19(3):213-7.

PMID:
11932144
23.

[Heart rupture in acute myocardial infarction: multicenter observational study of the coronary unit of Piedmont].

Pron PG, Angelino P, Varbella F, Bongioanni S, Masi AS, Iazzolino E, Bonfiglio G, Brusin MC, Mainardi L, Nicastro C, Bouslenko Z, Conte MR.

Ital Heart J Suppl. 2002 Feb;3(2):215-20. Italian. Erratum in: Ital Heart J 2002 Jun;3(6 Suppl):677.

PMID:
11926028
24.

Recent developments in carbapenems.

Bonfiglio G, Russo G, Nicoletti G.

Expert Opin Investig Drugs. 2002 Apr;11(4):529-44. Review.

PMID:
11922861
25.

In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.

Cafiso V, Messina C, Santagati M, Campanile F, Bonfiglio G, Stefani S.

Drugs Exp Clin Res. 2001;27(3):107-11.

PMID:
11447768
26.

Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?

Bonfiglio G.

Chemotherapy. 2001 Jul-Aug;47(4):239-42.

PMID:
11399859
27.

Novel streptogramin antibiotics.

Bonfiglio G, Furneri PM.

Expert Opin Investig Drugs. 2001 Feb;10(2):185-98. Review.

PMID:
11178336
28.
29.

A Kinetic Study on the Interaction between Tazobactam (A Penicillanic Acid Sulphone Derivative) and Active-Site Serine beta-Lactamases.

Perilli M, Franceschini N, Bonfiglio G, Segatore B, Stefani S, Nicoletti G, Tavio Perez Md, Bianchi C, Zollo A, Amicosante G.

J Enzyme Inhib. 1999 Nov;15(1):1-10.

PMID:
10938530
30.

Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison.

Nicoletti G, Bonfiglio G, Bartoloni A, Mattina R, Nicoletti P, Pecile P, Rescaldani R, Romeo MA, Russo G, Savarino O, Stefani S, Paradisi F.

Int J Antimicrob Agents. 2000 Aug;15(4):265-9.

PMID:
10929875
32.

A kinetic study on the interaction between tazobactam (a penicillanic acid sulphone derivative) and active-site serine beta-lactamases.

Perilli M, Franceschini N, Bonfiglio G, Segatore B, Stefani S, Nicoletti G, Perez MM, Bianchi C, Zollo A, Amicosante G.

J Enzyme Inhib. 2000;15(1):1-10.

PMID:
10850951
33.

Interaction of cefotetan and the metallo-beta-lactamases produced in Aeromonas spp. and in vitro activity.

Quiroga MI, Franceschini N, Rossolini GM, Gutkind G, Bonfiglio G, Franchino L, Amicosante G.

Chemotherapy. 2000 May-Jun;46(3):177-83.

PMID:
10765032
34.

First identification of an SHV-12 extended-spectrum beta-lactamase in Klebsiella pneumoniae isolated in Italy.

Laksai Y, Severino M, Perilli M, Amicosante G, Bonfiglio G, Stefani S.

J Antimicrob Chemother. 2000 Mar;45(3):349-51.

PMID:
10702555
35.

Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates.

Bonfiglio G, Cascone C, Azzarelli C, Cafiso V, Marchetti F, Stefani S.

J Antimicrob Chemother. 2000 Jan;45(1):115-7.

PMID:
10629022
36.

In vitro selection of glycopeptide-resistant variants of Enterococci.

Puntorieri M, Cafiso V, Santagati M, Messina C, Azzarelli C, Catalano V, Bonfiglio G, Giuseppe N, Stefania S.

Int J Antimicrob Agents. 1999 Aug;12(4):333-9.

PMID:
10493610
37.

Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey.

Bonfiglio G, Laksai Y, Franchino L, Amicosante G, Nicoletti G.

J Antimicrob Chemother. 1998 Dec;42(6):697-702.

PMID:
10052891
38.

Study on the in-vitro activity of LY333328 against gram-positive cocci.

Mezzatesta ML, Bonfiglio G, De Angelis L, Stefani S, Russo G.

J Antimicrob Chemother. 1998 Aug;42(2):266-8. No abstract available.

PMID:
9738850
39.

In vitro activity of piperacillin/tazobactam against 615 Pseudomonas aeruginosa strains isolated in intensive care units.

Bonfiglio G, Laksai Y, Franceschini N, Perilli M, Segatore B, Bianchi C, Stefani S, Amicosante G, Nicoletti G.

Chemotherapy. 1998 Sep-Oct;44(5):305-12.

PMID:
9732144
40.

Susceptibility survey of piperacillin/tazobactam and some beta-lactam comparators in Italy.

Stefani S, Bonfiglio G, Bianchi C, Zollo A, Nicoletti G.

Drugs Exp Clin Res. 1998;24(2):105-13.

PMID:
9675551
41.

Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.

Bonfiglio G, Carciotto V, Russo G, Stefani S, Schito GC, Debbia E, Nicoletti G.

J Antimicrob Chemother. 1998 Feb;41(2):307-10.

PMID:
9533479
42.

Fixed subaortic stenosis associated with hypertrophic cardiomyopathy: report of a rare familial occurrence.

Conte MR, Bongioanni S, Dall'Orto G, Nicastro C, Bonfiglio G, Morello M, Mangiardi L, Brusca A.

G Ital Cardiol. 1998 Jan;28(1):53-6.

PMID:
9493046
43.

In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates.

Bonfiglio G, Maccarone G, Mezzatesta ML, Privitera A, Carciotto V, Santagati M, Stefani S, Nicoletti G.

Chemotherapy. 1997 Nov-Dec;43(6):393-3.

PMID:
9395852
44.

An ARG403GLN beta-myosin heavy chain gene mutation identified in an Italian family with hypertrophic cardiomyopathy; description of clinical features of the family members.

Conte MR, Morelio M, Mangiardi L, Orzan F, Checco L, Bonfiglio G, Alfarano A, Camaschella C, Brusca A.

Eur Heart J. 1997 Jun;18(6):1033-4. No abstract available.

PMID:
9183600
45.

Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates.

Perilli M, Felici A, Oratore A, Cornaglia G, Bonfiglio G, Rossolini GM, Amicosante G.

Antimicrob Agents Chemother. 1996 Mar;40(3):715-9.

46.

[Hypertrophic obstructive cardiomyopathy in a patient with Turner syndrome].

Conte MR, Bonfiglio G, Orzan F, Mangiardi L, Camaschella C, Alfarano A, Brusca A.

Cardiologia. 1995 Dec;40(12):947-9. Italian.

PMID:
8901045
47.

Clinical isolate of a Xanthomonas maltophilia strain producing L-1-deficient and L-2-inducible beta-lactamases.

Bonfiglio G, Stefani S, Nicoletti G.

Chemotherapy. 1995 Mar-Apr;41(2):121-4.

PMID:
7758355
48.
49.
50.

Zinc ions and medium-dependent susceptibility to beta-lactams in Xanthomonas maltophilia.

Bonfiglio G, Livermore DM.

J Antimicrob Chemother. 1994 Jan;33(1):181-3. No abstract available.

PMID:
8157562

Supplemental Content

Loading ...
Support Center